CRT Capital Initiates St. Jude Medical With Buy

Analysts at CRT Capital initiated coverage on shares of St. Jude Medical

with a “buy” rating. The target price for St. Jude Medical is set to $80. St. Jude Medical shares have jumped 48.45% over the past 52 weeks, while the S&P 500 index has gained 19.69% in the same period. St. Jude Medical's shares gained 0.27% to close at $70.32 yesterday.